Drugs in development for toxoplasmosis: advances, challenges, and current status
P Holland Alday,1 Joseph Stone Doggett1,2 1Division of Infectious Diseases, Oregon Health & Science University, 2Portland Veterans Affairs Medical Center, Portland, OR, USA Abstract: Toxoplasma gondii causes fatal and debilitating brain and eye diseases. Medicines that are currently used to trea...
Saved in:
Main Authors: | Alday PH (Author), Doggett JS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxoplasmosis Recent Advances
Published: (2012) -
Management of severe sepsis: advances, challenges, and current status
by: Martin-Loeches I, et al.
Published: (2015) -
Human Pluripotent Stem Cell Culture: Current Status, Challenges, and Advancement
by: Sushrut Dakhore, et al.
Published: (2018) -
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
by: Hugo Geerts, et al.
Published: (2020) -
Advances in the diagnosis of ocular toxoplasmosis: Use of optical coherence tomography
by: Tessie Ferrer Mellor, et al.
Published: (2020)